Estrogen receptor beta (ERβ) subtype-specific ligands increase transcription, p44/p42 mitogen activated protein kinase (MAPK) activation and growth in human non-small cell lung cancer cells
- 31 August 2009
- journal article
- Published by Elsevier in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 116 (1-2) , 102-109
- https://doi.org/10.1016/j.jsbmb.2009.05.004
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Estrogen Receptor β Functions through Nongenomic Mechanisms in Lung Cancer CellsMolecular Endocrinology, 2009
- Estrogen promotes tumor progression in a genetically defined mouse model of lung adenocarcinomaEndocrine-Related Cancer, 2008
- Cancer Statistics, 2007CA: A Cancer Journal for Clinicians, 2007
- The Consensus Coding Sequences of Human Breast and Colorectal CancersScience, 2006
- Hormone replacement therapy in menopause and lung cancer: an updateEuropean Journal Of Cancer Prevention, 2006
- Lung dysfunction causes systemic hypoxia in estrogen receptor β knockout (ERβ −/− ) miceProceedings of the National Academy of Sciences, 2006
- Estrogen Receptor α and β are Prognostic Factors in Non–Small Cell Lung CancerClinical Cancer Research, 2005
- Estrogen and growth factor receptor interactions in human breast and non-small cell lung cancer cellsSteroids, 2005
- Creating a bioinformatics nationNature, 2002
- Expression, Function, and Clinical Implications of the Estrogen Receptor β in Human Lung CancersBiochemical and Biophysical Research Communications, 2001